<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The neurotrophins and the tyrosine kinase (Trk) B receptor may play a protective role in the pathophysiology of <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>In this study, the authors investigated whether reducing endogenous expression of TrkB-binding neurotrophins modifies the susceptibility to ischemic injury after 1-hour middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> followed by 23 hours of reperfusion in a filament middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> model </plain></SENT>
<SENT sid="2" pm="."><plain>Mice lacking both alleles for neurotrophin-4 (nt4-/-) or deficient in a single allele for brain-derived neurotrophic factor (bdnf+/-) exhibited larger cerebral <z:mpath ids='MPATH_124'>infarcts</z:mpath> compared to <z:mp ids='MP_0002169'>wild-type</z:mp> inbred 129/SVjae mice (68% and 91%, respectively, compared to controls) </plain></SENT>
<SENT sid="3" pm="."><plain>Moreover, lesions were larger (21%) in nt4-/- mice after permanent middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> </plain></SENT>
<SENT sid="4" pm="."><plain>Hence, expression of both NT4 and BDNF, and by inference the TrkB receptor, confers resistance to ischemic injury </plain></SENT>
</text></document>